104 related articles for article (PubMed ID: 461495)
1. Acute effects of parathyroid extract on renal vitamin D hydroxylases in Japanese quail.
Baksi SN; Kenny AD
Pharmacology; 1979; 18(4):169-74. PubMed ID: 461495
[TBL] [Abstract][Full Text] [Related]
2. Estradiol-induced stimulation of 25-hydroxyvitamin D3-1-hydroxylase in vitamin D-deficient Japanese quail.
Baksi SN; Kenny AD
Pharmacology; 1980; 20(6):298-303. PubMed ID: 6250169
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
5. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
Bikle DD; Rasmussen H
J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
[TBL] [Abstract][Full Text] [Related]
6. Hypocalcemia, but not PTH or hypophosphatemia, induces a rapid increase in 1,25(OH)2D3 levels in rats.
Fox J
Am J Physiol; 1992 Feb; 262(2 Pt 1):E211-5. PubMed ID: 1539647
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
8. Interrelationships between the key elements of the vitamin D endocrine system: 25-OH-D3-1-hydroxylase, serum calcium and phosphorus levels, intestinal 1,25(OH)2D3, and intestinal calcium binding protein.
Norman AW; Friedlander EJ; Henry H
Adv Exp Med Biol; 1977; 81():211-31. PubMed ID: 331899
[No Abstract] [Full Text] [Related]
9. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
10. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
Brandi L; Egfjord M; Olgaard K
Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone stimulation of 1,25-dihydroxyvitamin D3 production in antiestrogen-treated Japanese quail.
Baksi SN; Kenny AD
Mol Pharmacol; 1979 Nov; 16(3):932-40. PubMed ID: 530264
[No Abstract] [Full Text] [Related]
12. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
[TBL] [Abstract][Full Text] [Related]
13. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
14. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
Nesbitt T; Drezner MK; Lobaugh B
J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
[TBL] [Abstract][Full Text] [Related]
15. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659
[TBL] [Abstract][Full Text] [Related]
16. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
18. Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks.
Pike JW; Spanos E; Colston KW; MacIntyre I; Haussler MR
Am J Physiol; 1978 Sep; 235(3):E338-43. PubMed ID: 211856
[TBL] [Abstract][Full Text] [Related]
19. Respective roles of 25 hydroxy-vitamin D, PTH, phosphate and renal function for the 1-alpha-hydroxylase activity in primary hyperparathyroidism.
Frølich A; Nielsen BF; Transbøl I
Miner Electrolyte Metab; 1990; 16(4):210-5. PubMed ID: 2277605
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
